[TABLE OF CONTENTS]

1 INTRODUCTION OF GLOBAL RAT MODEL MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES

4 GLOBAL RAT MODEL MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS

5 GLOBAL RAT MODEL MARKET, BY TYPE
5.1 OVERVIEW
5.2 OUTBRED RATS
5.3 INBRED RATS
5.4 GENETICALLY MODIFIED RATS
5.5 HYBRID/CONGENIC RATS
5.6 CONDITIONED/SURGICALLY MODIFIED RATS
5.7 IMMUNODEFICIENT RATS

6 GLOBAL RAT MODEL MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 NUCLEAR TRANSFER
6.3 EMBRYONIC STEM CELL
6.4 MICROINJECTION
6.5 OTHERS 

7 GLOBAL RAT MODEL MARKET, BY SERVICE
7.1 OVERVIEW
7.2 CRYOPRESERVATION
7.3 BREEDING
7.4 REDERIVATION
7.5 GENETIC TESTING
7.6 QUARANTINE DEPENDING
7.7 OTHER

8 GLOBAL RAT MODEL MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 NEUROLOGY
8.4 IMMUNOLOGY
8.5 TOXICOLOGY
8.6 OTHERS

9 GLOBAL RAT MODEL MARKET, BY END-USE
9.1 OVERVIEW
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3 ACADEMIC & RESEARCH INSTITUTES
9.4 CONTRACT RESEARCH ORGANIZATIONS (CROS) 

10 GLOBAL RAT MODEL MARKET, BY GEOGRAPHY
10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 NORTH AMERICA MARKET SNAPSHOT
10.2.2 U.S.
10.2.3 CANADA
10.2.4 MEXICO

10.3 EUROPE

10.3.1 EUROPE MARKET SNAPSHOT
10.3.2 WESTERN EUROPE
10.3.2.1 THE UK
10.3.2.2 GERMANY
10.3.2.3 FRANCE
10.3.2.4 ITALY
10.3.2.5 SPAIN
10.3.2.6 REST OF WESTERN EUROPE
10.3.3 EASTERN EUROPE
10.3.3.1 POLAND
10.3.3.2 RUSSIA
10.3.3.3 REST OF EASTERN EUROPE

10.4 ASIA PACIFIC

10.4.1 ASIA PACIFIC MARKET SNAPSHOT
10.4.2 CHINA
10.4.3 JAPAN
10.4.4 INDIA
10.4.5 AUSTRALIA & NEW ZEALAND
10.4.6 ASEAN
10.4.7 REST OF ASIA PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
10.5.2 UAE
10.5.3 SAUDI ARABIA
10.5.4 SOUTH AFRICA
10.5.5 REST OF MEA

10.6 SOUTH AMERICA

10.6.1 SOUTH AMERICA MARKET SNAPSHOT
10.6.2 BRAZIL
10.6.3 ARGENTINA
10.6.4 REST OF SOUTH AMERICA

11 GLOBAL RAT MODEL MARKET COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPANY MARKET RANKING
11.3 KEY DEVELOPMENT STRATEGIES

12 COMPANY PROFILES

12.1 GENOWAY
12.1.1 OVERVIEW
12.1.2 FINANCIAL PERFORMANCE
12.1.3 PRODUCT OUTLOOK
12.1.4 KEY DEVELOPMENTS

12.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INCORPORATED
12.2.1 OVERVIEW
12.2.2 FINANCIAL PERFORMANCE
12.2.3 PRODUCT OUTLOOK
12.2.4 KEY DEVELOPMENTS

12.3 ENVIGO
12.3.1 OVERVIEW
12.3.2 FINANCIAL PERFORMANCE
12.3.3 PRODUCT OUTLOOK
12.3.4 KEY DEVELOPMENTS

12.4 COVANCE INCORPORATED
12.4.1 OVERVIEW
12.4.2 FINANCIAL PERFORMANCE
12.4.3 PRODUCT OUTLOOK
12.4.4 KEY DEVELOPMENTS

12.5 HORIZON DISCOVERY GROUP PLC
12.5.1 OVERVIEW
12.5.2 FINANCIAL PERFORMANCE
12.5.3 PRODUCT OUTLOOK
12.5.4 KEY DEVELOPMENTS

12.6 JANVIER LABS
12.6.1 OVERVIEW
12.6.2 FINANCIAL PERFORMANCE
12.6.3 PRODUCT OUTLOOK
12.6.4 KEY DEVELOPMENTS

12.7 TACONIC BIOSCIENCES, INCORPORATED
12.7.1 OVERVIEW
12.7.2 FINANCIAL PERFORMANCE
12.7.3 PRODUCT OUTLOOK
12.7.4 KEY DEVELOPMENTS

12.8. BIOMEDICAL RESEARCH MODELS (BIOMERE)
12.8.1 OVERVIEW
12.8.2 FINANCIAL PERFORMANCE
12.8.3 PRODUCT OUTLOOK
12.8.4 KEY DEVELOPMENTS